Rilexine
Loading...Rilexine Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
For use in dogs only. Not for use in humans. Keep this drug out of the reach of children. Antimicrobials, including penicillins and cephalosporins, can cause allergic reactions in sensitized individuals. Sensitized individuals handling such antimicrobials, including cephalexin, should avoid contact of the product with the skin and mucous membranes in order to minimize the risk of allergic reactions.
In case of ingestion by humans contact a physician immediately. Physicians may contact a Poison Control Center for advice concerning cases of ingestion by humans.
To obtain a copy of the Material Safety Data Sheet (MSDS), or to report adverse reactions, call Virbac at 1-800-338-3659.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
There is currently no usage information available for this product. We apologize for any inconvenience.
History
There is currently no drug history available for this drug.
Other Information
RILEXINE® Chewable Tablets are a chewable, bisected tablet supplied in 4 sizes containing 75 mg, 150 mg, 300 mg, and 600 mg of cephalexin. Cephalexin is a cephalosporin, beta-lactam, broad spectrum antibiotic. The full chemical name for cephalexin is 7-(D-α-amino- α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid monohydrate.
Sources
Rilexine Manufacturers
-
Virbac Ah, Inc
![Rilexine (Cephalexin) Tablet, Chewable [Virbac Ah, Inc]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Rilexine | Virbac Ah, Inc
The recommended dose is 22 mg/kg (10 mg/lb) of body weight twice daily for 28 days.
Appropriate culture and susceptibility tests should be performed before treatment to determine the causative organism and its susceptibility to cephalexin. Therapy with RILEXINE Chewable Tablets may be initiated before results of these tests are known; once the results become available, antimicrobial therapy should be adjusted accordingly. If acceptable response to treatment is not observed, then the diagnosis should be re-evaluated and appropriate alternative therapy considered.
Login To Your Free Account